Aider is a “pair-programming” tool that can use various providers as the AI back end, including a locally running instance of Ollama (with its variety of LLM choices). Typically, you would connect to ...

The key themes that defined the year behind us will also shape the one ahead. The most-read articles of 2025 tracked a return ...

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Programmers hold to a wide spectrum of positions on software complexity, from the rare command-line purists to the much more ...

MiniStudio is a Paris-based AI banner that rolled out in 2024 with just one IP, 'Fuzzlets' which has quietly become a ...

Working It is the FT's workplace, future of work and leadership brand, led by Isabel Berwick. Sign up for Isabel's weekly Working It newsletter (here) which offers a sideways glance at the week's big ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Gordon Scott has been an active investor and ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

The vulnerabilities may have been exploited in 'an extremely sophisticated attack against specific targeted individuals' using versions of iOS prior to iOS 26, as per Apple's security bulletin.